Upload
beulah
View
43
Download
0
Embed Size (px)
DESCRIPTION
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008. Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection Program [email protected] 514-2152. Outline for Today. Roles of the QIU and CHR Types of Post-Approval Events - PowerPoint PPT Presentation
Citation preview
Human Research Protection Program Training:
Post-Approval Event Reporting March 26, 2008
Lisa Voss, MPH, CIPAssistant Director, QIU
Human Research Protection Program
[email protected] 514-2152
3/26/08
Outline for Today
Roles of the QIU and CHR Types of Post-Approval Events Post-Approval Event Reports Forms Tips Q&A
3/26/08
What is the Role of the QIU?
Provide Quality Assurance (QA) and Quality Improvement (QI) activities
Work with the CHR to assure rights and welfare of human research participants and reduce risk
Front Desk Support GroupAdministrative Assistant IIs
Jessica LoomisMeri Figueroa Mario VelezDenisha Otis
--------------------------TEP for Data Entry
TEP for Filing
HRPP Director Sharon Friend
HRPP Associate Director Education and Screening Unit(Pre-CHR Review Activities)
Richard WagnerAnalyst V Supervisor
HRPP Associate Director CHR Review Unit
(CHR Review Activities) Systems Coordination
John HeldensAnalyst V Supervisor
HRPP Assistant Director Quality Improvement Unit
(Post CHR Approval Activities)Lisa Voss
Analyst V Supervisor
Committee CoordinatorsLaurel Heights
Karen Chao – Analyst IVKate Nolan—Analyst II
Committee CoordinatorsMt. Zion
Michael Thomas -- IVAnnette Bugatto -- II
Committee CoordinatorsParnassus
Liz Tioupine -- IVWendy Stephens -- II
Committee CoordinatorsSFGH
Elizabeth Mendelsohn -- IVTerry Colbert -- II
QIU Group
Maria Bahn – Analyst IVBeth Shields - Analyst IV
TBN – Analyst II
Education and Assessment Group
Joanne Mickalian – Analyst IVAnita Katona – Analyst IV
TBN - Analyst IV
Fred Hendrickson – Analyst IIMegan Sullivan – Analyst II
HRPP Operations Manager TBD
Analyst II Supervisor
HRPP – Human Research Protection ProgramCHR – Committee on Human ResearchQIU – Quality Improvement Unit
3/26/08
QIU Activities
Review post-approval event reports Conduct routine site reviews of
clinical research studies Conduct directed or for cause on-
site reviews of clinical research studies
Emergency Use requests
3/26/08
Post-Approval Event Reports
Adverse Events Protocol Violations Protocol Incidents
Subject or Researcher Concerns and Complaints
Approval Lapses
3/26/08
Post-Approval Event Reports
Investigator Brochure updates Safety Information or Significant New
Finding DSMB/DMC Report Audit Reports Holds on Study Activities Subject Injury Complaints Study Close-Out Reports
Adverse Events (AE’s) and Adverse Events (AE’s) and Serious Adverse Events (SAE’s)Serious Adverse Events (SAE’s)
Determining What To Determining What To Report and What NOT To Report and What NOT To
ReportReport
3/26/08
Adverse Events (Internal)
PI determines event to be: Definitely, Probably, or Possibly Related
AND Serious or Unexpected
Report within 10-working days on Internal AE Reporting Form
3/26/08
Adverse Events (Internal)
Death – Unrelated to research as determined by the PI
Only for interventional studies
Report at time of Renewal or Major Modification via the AE Summary Log
3/26/08
Adverse Events (External)
PI determines that the event: Changes the study risks or benefits
OR Requires a modification to the CHR
Application or the Consent form
Report within 10-working days on External AE Reporting Form
3/26/08
Adverse Events (External)
AE’s that do not meet the previous criteria: Reporting not required by CHR If Sponsors requires reporting use the
AE Summary Log
Protocol ViolationsProtocol Violations
Determining What To Determining What To Report and What NOT To Report and What NOT To
ReportReport
3/26/08
Protocol Violations (Major)
Unapproved changes, deviations, or departures from study design that are: Under the PI’s control and Have not been reviewed and approved by the CHR
AND May affect participants rights, safety or well-being
or impact study data
Report within 10-working days on Violation/Incident Reporting Form
3/26/08
Protocol Violations (Minor)
Also known as Protocol Deviations Unapproved changes, deviations, or
departures from study design that are: Under the PIs control and Have not been reviewed and approved by the
CHRBUT
Do not impact participants rights, safety or well-being or impact study data
Reporting NOT Required – document in study file
Protocol IncidentsProtocol Incidents
Determining What To Determining What To Report and What NOT To Report and What NOT To
ReportReport
3/26/08
Protocol Incidents (Major)
Any problematic or unanticipated event related to: Conduct of the study or subject participation and
involves significant potential harm to the participants.
Subject Complaints
Report within 10-working days on Violation/Incident Reporting Form
3/26/08
Protocol Incidents (Minor)
Any problematic or unanticipated event related to: Conduct of the study or subject participation
and does not involve significant potential harm to the participants.
Subject Complaints
Reporting NOT Required
Other Events and Safety Other Events and Safety InformationInformation
Other ReportsOther Reports
3/26/08
Other Events and Safety Reports
Investigator Drug Brochure Safety Information or Updates DSMB/DMC Reports Audit Reports Hold on Study Activities
Report within 10-working days on Reporting Form
3/26/08
Study Close-Out Reports
Updates CHR on conduct of study since last renewal
Required for: Studies that received full-committee
review at any time Expedited Review studies that
involved participant contact
3/26/08
When NOT to Submit
Do not close-out a study if: local enrollment to the study is ongoing local research-related interventions are
ongoing local participant follow-up is ongoing data analysis or manuscript preparation that
involves use or access to individually identifiable information is ongoing
An IRB approved Tissue Bank is approved under the study
CHR and QIU Role in Post-CHR and QIU Role in Post-Approval Event Reports Approval Event Reports
3/26/08
CHR Review Process
Note report and keep in CHR file Request:
Additional information Require a modification
Flag study for future educational efforts, website guidance, and/or monitoring visits
Temporarily or permanently suspend and terminate enrollment in study
3/26/08
CHR Review Outcome
Determine if the report is an: Unanticipated Problem or Serious or Continuing Non-
Compliance
3/26/08
Unanticipated Problem
An Unanticipated Problem involving risk to participants and or others, is defined on the basis of whether the event is:
Unanticipated or unexpected. Involves risks to participants or others. Related to the research
3/26/08
Serious Noncompliance
Failure to follow state or federal regulations for protection of the rights and welfare of study participants, University policies or the requirements or determinations of the CHR and that, in the judgment of the CHR Chair, Vice Chair, convened CHR Panel or AVC-R, results in, or indicates a potential for:
3/26/08
Serious Noncompliance
a) a significant risk to enrolled or potential participants or others, or
b) compromises the integrity of the study.
3/26/08
Continuing Noncompliance
Pattern of noncompliance that, in the judgment of the CHR Chair, Vice-Chair, convened CHR Panel or the AVC-R, suggests:
the likelihood that instances of noncompliance will continue without intervention.
3/26/08
CHR Regulatory Reporting Requirements
Federal Departments Office for Human Research Protection (OHRP) FDA
SF Veterans Affairs (if VA study) Associate Vice Chancellor for Research UCSF Legal Affairs (in certain cases) Study Sponsor Other offices or groups as required by the
nature of the study
Top Tips and Top Tips and Additional Discussion Points Additional Discussion Points
3/26/08
Tips
Submit reports only once: either by fax or campus mail
Consult with the QIU Identify CHR Approval (H number)
and PI when calling PI must sign all post-approval
event reports
3/26/08
Ask Questions
Ask your PI or Mentor Call the QIU: 415-476-1814 Email QIU: [email protected] http://www.research.ucsf.edu/
chr/